Navigation Links
Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
Date:5/31/2013

SAN BERNARDINO, Calif., May 31, 2013 /PRNewswire/ -- No other medical technology company can make the claim they've been solely focused on "Saving Lives with Proton Therapy," for more than 20 years. However, San Bernardino-based Optivus Proton Therapy, Inc. (Optivus) (http://www.optivus.com), a medical device engineering company, is celebrating its 20th Anniversary as pioneers in this high-tech medical technology field, having first launched in 1993.

The 20th Anniversary festivities for Optivus employees and their families will take place on the actual anniversary date of June 1.

"When we started more than 20 years ago, there was an overtone of pessimism in the radiation oncology field about proton beam therapy for the treatment of cancer and other diseases – institutions and radiation oncologists just weren't sure it would ever be profitable or practical," Jon W. Slater , Founder and CEO says. "But proton therapy stood the 'test of time,' and Optivus has come out as a leader within our industry. Our engineering team built the first hospital-based proton treatment center in the world at the Loma Linda University Medical Center in Loma Linda, C.A. (LLUMC)."

"The advances Optivus has made working with the physicians, physicists and scientists at LLUMC and other institutions over the last 20 years have resulted in a highly advanced, efficient and safe medical device," said David Lesyna , Vice President of Engineering.

Optivus President David Stokes remarked, "The key to our longevity is in our commitment to providing safe and efficient technology to benefit cancer patients and their families. Our technology at LLUMC has been used to treat more patients for more disease types than any other center of its kind – more than 17,000 patients by early 2013.  That's nearly a quarter of all patients treated with protons worldwide. You won't find that with any other proton therapy technology provider."

About Proton Radiation Therapy

Proton radiation therapy is the most accurate form of radiation treatment available today. It is ideal for treating cancers of the prostate, brain, lung, and tumors in children as well as many other conditions. The precision of the proton radiation beam allows few to no side effects as healthy tissue surrounding the disease is spared. Ultimately, this results in a better quality of life for the patient both during and after treatment.

About Optivus Proton Therapy, Inc.

In 1988 Loma Linda University Medical Center in Southern California undertook the challenge of building the world's first hospital-based Proton Beam Cancer Treatment Center under the planned Children's Hospital Wing. The facility would consist of three gantry rooms and two fixed-beam rooms.

In October of 1990, the first treatment room was fully operational and shortly thereafter, the original engineering team, led by Jon W. Slater , was entrusted with the technical enhancement and maintenance of the entire treatment center.

To meet future demands for this life-saving technology, within commercial markets, the engineering team transformed into a commercial business entity in 1993. The company was founded on principals of continuous excellence in design and development of this disease treatment technology.

Optivus' product, the Conforma 3000®, is FDA cleared and in its 7th design generation. It is a synchrotron accelerator based system that is modular and scalable to ensure upgrades and enhancements can be achieved without interrupting patient treatment. With over $150M in upgrades since 1990, (after the first patient was treated on the system,) the Optivus system at LLUMC has remained a leader in cutting edge technology.

Contact:
Lisa Pizzi
Optivus Proton Therapy, Inc.
909-799-8367 
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Optivus Proton Therapy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Jeffrey Epstein, New York Philanthropist, Funds Pioneering Cancer Metastasis Research at Mount Sinai
2. Fifteen Pioneering Inventors Nominated for European Inventor Award
3. Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
4. Society of Interventional Radiology: Pioneering specialty reaches out
5. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
6. Pioneering the Lap Band to Sleeve Gastrectomy Conversion
7. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
8. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
9. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
10. CCS Medical Announces Enhanced Product Formulary
11. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... , Feb 24, 2017 ... Committee,s proposal for a new Board of Directors that ... The 2016-2017 Nomination Committee comprises representatives of the company,s ... quarter of 2016 who have accepted a seat on ... The composition of the 2016-2017 Nomination Committee was as ...
(Date:2/24/2017)... Feb 24, 2017 Research and Markets has ... and Strategies - 2016" report to their offering. ... The latest research Urinary ... data and benchmarks in the global Urinary Incontinence market. The ... are the key drugs marketed for Urinary Incontinence and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that ... Chairman of the Management Committee when IFN was originally formed in 2002 where he ... and development of the business plan. He became the first paid employee of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, ... thought leadership , media relations, social media, content marketing and SEO, is ... powered through Act-On, an intuitive marketing automation platform. , Rosica will now offer ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. ... from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
Breaking Medicine News(10 mins):